10. Share-Based Compensation

The Company recognized $2.9 million and $2.2 million of expense related to share-based compensation during the three months ended June 30, 2025 and 2024, respectively, and $6.2 million and $3.8 million during the six months ended June 30, 2025 and 2024, respectively, which was measured based upon the fair value of the awards at the grant date.

The Company granted approximately 203,000 and 57,000 restricted stock units during the three months ended June 30, 2025 and 2024, respectively, and approximately 590,000 and 341,000 restricted stock units during the six months ended June 30, 2025 and 2024, respectively. In addition, the Company granted 67,000 and 25,000 stock options during the six months ended June 30, 2025 and 2024, respectively. No stock options were granted during the three months ended June 30, 2025 and 2024.

There were 500 and 10,000 options exercised during the three months ended June 30, 2025 and 2024, respectively, for which the Company received zero and $0.2 million, respectively, in cash. The intrinsic value of options exercised during the three months ended June 30, 2025 and 2024 was zero and $0.1 million, respectively. There were 500 and 20,000 options exercised during the six months ended June 30, 2025 and 2024, respectively, for which the Company received zero and $0.3 million, respectively, in cash. The intrinsic value of options exercised during the six months ended June 30, 2025 and 2024 was zero and $0.2 million, respectively.